Clinical trial
Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type…
NCT00147745 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00147745 |
|---|---|
| Title | Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes |
| Official title | Effects of Colesevelam on Insulin Sensitivity in Type 2 Diabetes Mellitus |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Colesevelam, Colesevelam matching placebo, Insulin glargine (Lantus) |
| Enrollment | 36 |
| Start date | Jun 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 7, 2005 |
| Last update posted | Apr 2, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: